期刊文献+

基质金属蛋白酶2在鼻咽癌组织中的表达及其与肿瘤细胞生物学行为的关系

Expressive activity of matrix met alloproteinase-2 in nasopharyngeal carcinoma tissues and its implications in malignent biological behavior
下载PDF
导出
摘要 目的研究基质金属蛋白酶2(MMP2)在鼻咽癌组织中的表达及其与鼻咽癌细胞生物学行为的关系。方法采用免疫组化Elivision Plus二步法对50例鼻咽癌组织、15例炎性鼻咽黏膜组织的MMP2表达活性进行检测与比较。结果鼻咽癌组织中的MMP2表达显著高于炎性鼻咽黏膜组织(P<0.05),并随鼻咽癌临床浸润分期的升高和淋巴结转移的发生而上调,差异具有统计学意义(P<0.01)。结论MMP2在鼻咽癌细胞突破基底膜向外扩散及转移中可能起着重要作用,对于判断鼻咽癌细胞的侵袭性及估计其预后中有一定意义。 Objective To investigate the expressive activity of matrix met alloproteinase-2 (MMP-2) in the tissues of nasopharyngeal carcinoma (NPC) and its implications in the biological behavior of the tumor based on a study carried out in a group of clinical samples. Methods The expressive activity of MMP-2 was determined by immunohistochemical Elivision Plus methods in 50 cases of NPC tissues and 15 tissue samples of inflammatory nasopharyngeal epithelia to analyze the expressive difference in various tissues and its implications in the biological behavior of the tumor. Results The Positive rate of MMP-2 was significantly higher in N-PC tissues than that in inflammatory tissues (P〈 0.05) and was significantly relevant with the infiltrating grading in local tissue and lymphatic metastasis rate in the neck. Conclusions MMP-2 may Play a critical role in the Pathological Process of tumor cells to degrade the basement membrane to in vade surrounding tissues and to form metastatic lesions in neck lymph nodes. Determination of MMP-2 activity in the tumor tissues should be of some significance in Predicting the invasion Potentiality of NPC cells and in the evaluation on the Prognosis of such cases.
出处 《中国中西医结合耳鼻咽喉科杂志》 2008年第1期16-19,共4页 Chinese Journal of Otorhinolaryngology in Integrative Medicine
基金 广东省深圳市科技计划项目(编号2003042871)
关键词 鼻咽肿瘤 基质金属蛋白酶-2 临床意义 Nasopharyngeal carcinoma MMP-2 Clinical implications
  • 相关文献

参考文献10

  • 1Nomura H,Fujimoto H,Seiki M,et al.Enhanced Production atrixmet alloproteinase and activation of matrix met alloproteinase-2(ge-latinase A)in human gastric carcinomas[J].Int J Cancer,1996, 69.9-16.
  • 2Yoshizaki T, Sato H,Furukawa M.Recent advances in the regulation of matrix met alloproteinase 2 activation.from basic research to clinical implication (Review).Oncol Rep,2002,9 (3):607-611.
  • 3Franchi A,Santucci M,Masini E,et al.Expression of matrix met aIIoproteinase l,matrix met alloproteinase 2,and matrix met alloproteinase.9 in carcinoma of the head and neck.Cancer,2002,95. 1902-1910.
  • 4Krecicki T, Zalesskazkrecicka M,Jelen M,et al. Expression of type IV collagen and matrix met alloproteinase2(type IV collagenase)in relation to nodal status in larynzgeal cancer.Clin Otolaryngol, 2001,26.469-472.
  • 5Jurasz P, Sawicki G,Duszyk M,et al.Matrix et alloproteinase 2 in tu-mor cellzinduced Platelet aggregation.regulation by nitric oxide.Cancer Res,2001,61(1):376-382.
  • 6Di-Nezza LA,Misajon A,Zhang J,et al.Presence of active gelatinases in endometrial carcinoma and correlation of matrix met alloproteinase expression with increasing tumor grade and invasion. Cancer, 2002,94(5). 1466-1475.
  • 7罗彬,梅同华,张桂蓉.肺癌MMP-2和TIMP-2的表达及意义[J].中国现代医学杂志,2004,14(21):61-62. 被引量:1
  • 8Kumaki F, Matsui K,Kawai T, et al.Expression of matrix met alloproteinasesin invasive Pulmonary adenocarcinom a with bronchioloal veolarcomponent and atypical adenomatous hyperplasia[J].Am J Pathol,2001,159(6):2125-2135.
  • 9Sustinen M,Kainulainen T, Hurskainen T, et al. Expression of matrix met alloproteinases (MMPI and 2) and their inhibitors (TIMPI,2,and 3) in oral lichen Planus,dySPLasia,oral squamous andlymph node metastasis[J].Br J Cancer,1998,77. 2239-2245.
  • 10杨大运,丁翠敏,孙志学,金普乐,王平.基质金属蛋白酶-2及其抑制剂在肺癌侵袭转移中作用的研究[J].国外医学(呼吸系统分册),2005,25(6):407-409. 被引量:5

二级参考文献10

  • 1Delebecq TJ, Porte H, Zerimech F, et al. Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer [J]. Clin Cancer Res, 2000, 6 (3):1086-1092.
  • 2Kumaki F, Matsui K, Kawai T, et al. Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia[J].Am J Pathol, 2001, 159(6): 2125-2135.
  • 3Nawrocki B, Polette M, Marchand V, et al. Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses [J].Int J Cancer, 1997, 72(4): 556-564.
  • 4Still K, Robson CN, Autzen P, et al. localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metallopreinase-2 (TIMP-2) in human benign and malignant prostatic tissue[J]. Prostate, 2000, 42(1): 18-25.
  • 5Morkve O, Learum OD. Flow cytometry measurement of P53protein expression and DNA content in paraffin embedded tissue from bronchial carcinoma. Cytometry, 1991,12(5) :438-444.
  • 6Thomas P, Khokka R, Shepherd FA, et al. Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer. J Pathol, 2000,190(2): 150-156.
  • 7Fang J, Shing Y, Wiederschain D, et al. Matrix metalloproteinase2 is phenotype in a tumor model. Proc Natl Acad Sci USA,2000,97(8) :3884-3889.
  • 8Gonzalez AG,Iturrea C,Vadillo F,et al. 72ku(MMP-2) and 92ku (MMP-9) type Ⅳ collagenase production and activity in different histologic types of lung cancer. Pathobiology, 1998,66(1) :5-16.
  • 9Ylisirnio S, Hoyhtya M, Turpeenniemi HT, et al. Serum MMP-2、-9 and TIMP-1、-2 in lung cancer-TIMP-1 as a prognostic marker. Anticancer Res,2000(2): 1311-1316.
  • 10Pei XH, Nakanishi Y, Takayama K, et al. Granulocyte,granulocyte-macrophage and macrophage colonystimulting factors can stimulate the invasive capacityof human lung cancer cells. Br J Cancer,1999,79(1) :40-46.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部